Revenue grew 7.4% YoY and 2.3% QoQ, with EBITDA margin expanding to 16.1% and PAT up 51.3% YoY. Deal signings rose 20% YoY, cash reserves increased, and DSO improved, while BFSI and Lifesciences led growth amid macro challenges.Original document: Birlasoft Limited [BSOFT] Slides Release — Jul. 28 2…
Revenue grew 7.4% YoY and 2.3% QoQ, with EBITDA margin expanding to 16.1% and PAT up 51.3% YoY. Deal signings rose 20% YoY, cash reserves increased, and DSO improved, while BFSI and Lifesciences led growth amid macro challenges.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
